Did the Demand for Crestor Shrink when Lipitor’s Patent Expired?

David Zimmer

Journal of Industry, Competition and Trade, 2018, vol. 18, issue 2, No 2, 139-149

Abstract: Abstract This paper uses micro-level data from the Medical Expenditure Panel Survey to investigate whether, following the expiration of Lipitor’s patent, demand for Crestor shrank. The topic holds important policy implications owing to rapidly growing drug spending, because aggregate drug spending could potentially be reduced if insurers introduced incentives that encouraged patients to switch away from name-brand drugs, like Crestor, toward cheaper generic competitors. This paper produces several findings. The expiration of Lipitor’s patent does not appear to have significantly affected the overall market for Crestor. However, patients enrolled in private insurance do appear to have reduced Crestor usage by about 13%. Medicaid patients who used Crestor prior to the change in Lipitor’s patent status also appear to have reduced their Crestor usage by a relatively sizable amount. Finally, the expiration of Lipitor’s patent appears to have resulted in an 18% increase in the strength of a typical Crestor pill, which might be interpreted as a de facto price decrease for Crestor.

Keywords: Substitutes; Event study; Difference-in-difference; Count variables (search for similar items in EconPapers)
JEL-codes: H51 I11 (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10842-017-0255-2 Abstract (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:kap:jincot:v:18:y:2018:i:2:d:10.1007_s10842-017-0255-2

Ordering information: This journal article can be ordered from
http://www.springer. ... on/journal/10842/PS2

DOI: 10.1007/s10842-017-0255-2

Access Statistics for this article

Journal of Industry, Competition and Trade is currently edited by Karl Aiginger, Marcel Canoy and Michael Peneder

More articles in Journal of Industry, Competition and Trade from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().